EFTA Document EFTA01450729
William Blair & Company, LLC. Exhibit 1 ARIAD Pharmaceuticals, Inc. Sum-of-Parts Fair Value (dollars in thousands) Drug Peak Sales Stage of Development Estimated Launch Date Probability of Commercialization Percentage of Sales to Company Probability. Adjusted NPV Value per Share Percentage of Fair Value Iclusig-CML 9746.822 Marketed January 2013/ 100% 100% $1,843,975 $9.85 83.4% Worldwide July 2013 AP28113—ALK* NSCLC S280918 Phase Ifl I 1-12 2016 81% 100% $3
Summary
William Blair & Company, LLC. Exhibit 1 ARIAD Pharmaceuticals, Inc. Sum-of-Parts Fair Value (dollars in thousands) Drug Peak Sales Stage of Development Estimated Launch Date Probability of Commercialization Percentage of Sales to Company Probability. Adjusted NPV Value per Share Percentage of Fair Value Iclusig-CML 9746.822 Marketed January 2013/ 100% 100% $1,843,975 $9.85 83.4% Worldwide July 2013 AP28113—ALK* NSCLC S280918 Phase Ifl I 1-12 2016 81% 100% $3
Ask AI About This Document
Extracted Text (OCR)
Related Documents (6)
EFTA Document EFTA01297437
Gratitude America - Google Search Page 1 of 1 403/, GrablUde IntoCa ck Alf Nen fl eas %know Maca atre 8-1linaS TWA, ;mow 44 300.033.4,6Sn 4031 SKWast GratitudeAmerica www.orasiudeamenetwei HONORING OUR. HEROES 'tannin Ow goner dew Reba. Restore. Recreate Reruns DotterteAppty lot a Reheat GratitudoAmetrices wassmn to 10 pomride Retreats Leadership Reba. Reface. & Reesman Out *Vets dem* a supoorton Van mutts Item gratiluleamened org • GratitudeAmerica. Inc - Home j Facebook
1 May 1 1255-May 6 237_Redacted.pdf
Kristen M. Simkins me: Sent Tn: Subject: Atladimem: LT. THOMAS E. ALLEN JR Thomas S. Allen. Jr. Sunday. May BIL EDIE 12:55 AM Allyson FL Dwell; Brenda McKin1e?c C. Kay Wandring: Caitlyn D. Neff: Daniel?le Minarch?lck: JeFFrey' T. Hite; Jon D. Fisher. Jonathan M. Mfl?n-der. Joseph 5. Kolenorluan Mendez: Kevin T. Jeirles; [any Lidgett Lee R. Shea??er: Lorinda L. Brown.- Matti-new T. Fishet: Melanie Gordan; Michael S. Woods Richard C. 5mm; Shephanie D. Calander?mtus Report SMDIE 20150501004
11 MAY 25-MAY 27 901_Redacted.pdf
Kristen M. Simkins From: Irons, Janet Sent: Wednesday, May 25, 2016 11-29 AM To: Richard C. Smith Cc: Jeffrey T. We Subject: Meeting with Prison Society tomorrow Hello Warden Smith, I'm writing in preparation for our meeting with you and Director Hite tomorrow at 9:30 to talk about the Law Library. We have been in touch with Kim Kelmor, Assistant Director ofthe Law Library at Penn State, who has experience with prison libraries. She has helpfully provided us with some questions and guida
15 July 7 2016 - July 17 2016 working progress_Redacted.pdf
Kristen M. Simkins From: Sent: To: Cc: Subject: Irons, Janet < Tuesday, July 12, 2016 10:47 AM Richard C. Smith Hello Warden Smith, mother is anxious to hear the results of your inquiry into her daughter's health. I'd be grateful if you could email or call me at your earliest convenience. I'm free today after 2 p.m. Alternatively, we could meet after the Prison Board of Inspectors Meeting this coming Thursday. Best wishes, Janet Irons 1 Kristen M. Simkins From: Sent:
EFTA Document EFTA01465999
Equity Research Healthcare I Biotechnology ARIAD Pharmaceuticals, Inc. Iclusig Comes Back With a New Label and REMS; Upgrade to Outperform and Increase Price Target to $12 On Friday, December 20, Ariad announced that it has reached agreement with the FDA for immediate reauthorization of Iclusig marketing in the United States, with a narrower label and accompanying Risk Mitigation Strategy (REMS) and postmarketing requirements (PMRs) Ariad plans to resume shipping of Iclusig by midJanu
Gratitude America - Google Search
DOJ EFTA Data Set 10 document EFTA01297437
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.